This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

QAD Upgrade Offers Strategic Support For Life Sciences Manufacturing Company Growth

QAD Inc. (NASDAQ:QADA)(NASDAQ:QADB), a leading provider of enterprise software and services for global manufacturing companies, announced today that Laerdal A/S, a leading manufacturer of CPR equipment and resuscitation training devices, is deploying the latest edition of QAD Enterprise Applications across their global operations.

“The latest release of QAD Enterprise Applications offered so many new capabilities making it easy to arrive at the decision to upgrade,” said Egil Mathisen, CFO, Laerdal Medical “In addition to the functionality offered by the solution, QAD’s industry knowledge of the medical device marketplace will help us to rapidly implement a global core model across all of our sites utilizing QAD’s best practice process maps.”

Laerdal chose to upgrade to QAD Enterprise Applications due to its ability to support flexible business processes across multiple business entities. Additionally, QAD’s Enterprise Applications supports multiple languages and internationalization which will support Laerdal’s global growth plans.

QAD’s solution supports critical requirements needed for life sciences manufacturing companies who must demonstrate regulatory compliance to current good manufacturing practice (cGMP). In particular, supporting Corrective and Preventative Actions (CAPA), eSignature, Device History Records as well as tools to assist in validation.

The QAD Enterprise Applications deployment will give Laerdal access to QAD’s market leading .NET User Interface and enable its users to achieve greater personal productivity. With built-in Analytics and Reporting, QAD Enterprise Applications empower users to quickly view trends within the system and easily drill down into the data, providing the flexibility and accuracy needed to answer questions as they arise and make informed decisions.

“We are excited to see QAD Enterprise Applications Enterprise Edition align with our customers’ strategic goals,” said Steve Gardner, EMEA Vice President Sales & Marketing for QAD. “The application is designed to address the challenges our manufacturing customers are facing today – and to help get them ready for the economic recovery of tomorrow.”

To learn more about QAD Enterprise Applications, visit

About Laerdal

Laerdal is a manufacturer of medical equipment and medical training products, Laerdal's CPR training manikin 'Resusci Anne' is widely used throughout the world. Laerdal has over the years established sales operations in 23 countries and manufacturing and R&D operation units in four different locations. The company has 1400 employees.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.06 -0.60%
FB $117.87 -0.16%
GOOG $701.93 0.90%
TSLA $213.75 -4.00%
YHOO $37.03 2.90%


Chart of I:DJI
DOW 17,650.65 -0.61 -0.00%
S&P 500 2,049.81 -1.31 -0.06%
NASDAQ 4,720.7820 -4.8570 -0.10%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs